CLL Topics Banner: Therapies, Research and Patient Education for Chronic Lymphocytic Leukemia
CLL Topics Home Navigation Topics Alert Learning Tools About Us Feedback Feedback
Full Menu

Topics Alert

  • el
  • pt
  • world balloon

    Topics Alert Archive

    Alert Number 274

    Single agent fludarabine: Don't do it

    Date: February 10, 2024

    I get suspicious when any drug is crowned the de-facto “gold standard” without the necessary clinical trials to back it up.

    That has been the case with fludarabine monotherapy.  Don’t get me wrong, fludarabine is still a very potent and important drug in the treatment of CLL.  It is just that too many oncologists use this drug as the slam-dunk choice immediately after diagnosis, with no prognostic testing and no second thought for its appropriateness to the individual patient standing in front of them.  Now the verdict is in:  fludarabine monotherapy greatly increases the chances of potentially life threatening autoimmune disease (AIHA), and it is far safer to use it in combination with other drugs.  The latest article on our website Single Agent Fludarabine spells out the details.

    I am sure there are some patients out there reading this review, who have already been there, done that:  patients who were treated with the supposed gold-standard fludarabine, and may have developed AIHA as a consequence.  I can understand your bitterness, your sense of having been let down by the very system that is supposed to protect you.  I am afraid there is no way to undo the past, no way to un-ring the bell that has been rung.  The best you can do is to put it behind you as so much murky water under the bridge and go forward with the determination not to be blind-sided again.

    Our review is for the benefit of those that have not yet made these therapy decisions.  It seems the trickle down of hard won knowledge from the experts to the local providers of healthcare takes a good long while.  It will eventually get there, but in the meantime I think it would be a shame if newly diagnosed members of our patient community have to pay for the price for the slow pace.  I will do my best to keep you up to date on the latest information, so that you are ahead of the curve even if your doctor is not.

    But no one can be a better advocate for your health than you.  No one has more skin in this game than you.  If you cannot be bothered to learn and watch out for what may come to bite you down the road, who will? Stay tuned, stay informed, and stay proactive.  The life you save will be your own. 

    Be well,

    Chaya

    NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.


    Go to Alert Archive Listing

    You may also retrieve a different Alert,
    by entering a new Alert number here
    (in the range 1 to 309)

     

    ———

    Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.


    Copyright Notice:

    Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.

    All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.

    However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.

    ———

    crest

     

    GuideCompass
    up arrow